Search of: 00171977 OR 00028002 OR 00278876 OR 00116935 OR 00025246 OR 00041197 OR 00103168 OR 00112632 OR 00363103 OR 00367861 OR 00500188 [ID-NUMBER] - List Results

Found 11 studies with search of:

00171977 OR 00028002 OR 00278876 OR 00116935 OR 00025246 OR 00041197 OR 00103168 OR 00112632 OR 00363103 OR 00367861 OR 00500188 [ID-NUMBER]

Hide studies that are not seeking new volunteers.

Display Options

Rank

Status

Study

1

Completed

Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor

Condition:	Gastrointestinal Stromal Tumor
Interventions:	Drug: imatinib mesylate; Procedure: adjuvant therapy; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Age Groups:	Adult / Senior
Phase:	Phase II

2

Recruiting

Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

Condition:	Gastrointestinal Stromal Tumor
Interventions:	Drug: imatinib mesylate; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Age Groups:	Adult / Senior
Phase:	Phase II

3

Active, not recruiting

Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

Condition:	Sarcoma
Interventions:	Drug: imatinib mesylate; Drug: imatinib
Age Groups:	Adult / Senior
Phase:	Phase III

4

Active, not recruiting

Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery

Condition:	Gastrointestinal Stromal Tumor
Interventions:	Drug: imatinib mesylate; Procedure: adjuvant therapy
Age Groups:	Child / Adult / Senior
Phase:	Phase II

5

Recruiting

Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing c-Kit: Interruption After 5 Years vs Maintenance

Conditions:	Sarcoma; Gastro-Intestinal Stromal Tumors (GIST)
Intervention:	Drug: interruption of Glivec®
Age Groups:	Adult / Senior
Phase:	Phase III

6

Recruiting

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor

Condition:	Gastrointestinal Stromal Tumor
Interventions:	Drug: imatinib mesylate; Procedure: adjuvant therapy
Age Groups:	Adult / Senior
Phase:	Phase III

7

Completed

Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation

Conditions:	Sarcoma; Gastrointestinal Stromal Tumors
Intervention:	Drug: Imatinib mesylate (Glivec)
Age Groups:	Adult / Senior
Phase:	Phase II

8

Completed

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

Condition:	Gastrointestinal Stromal Tumors
Intervention:	Drug: Imatinib Mesylate
Age Groups:	Adult / Senior
Phase:	Phase IV

9

Active, not recruiting

Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery

Condition:	Gastrointestinal Stromal Tumor
Interventions:	Drug: imatinib mesylate; Other: placebo
Age Groups:	Adult / Senior
Phase:	Phase III

10

Active, not recruiting

Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST

Condition:	Gastrointestinal Stromal Tumors
Intervention:	Drug: Imatinib Mesylate
Age Groups:	Child / Adult / Senior
Phase:	Phase II

11

Recruiting

Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)

Condition:	Gastrointestinal Stromal Tumors
Intervention:	Drug: Imatinib mesylate
Age Groups:	Adult / Senior
Phase:	Phase II

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.

RSS Feeds for studies found by your search that were:

First received in the last 14 days,

Last updated (includes received) in the last 30 days

Download Options